Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1952 2
1957 1
1959 1
1960 1
1962 1
1963 1
1964 4
1965 2
1966 1
1967 3
1968 1
1969 6
1970 2
1971 4
1972 3
1973 4
1974 8
1975 5
1976 1
1977 2
1978 2
1979 7
1980 3
1981 5
1982 3
1983 4
1984 4
1985 5
1986 2
1987 4
1988 7
1989 3
1990 3
1992 6
1993 2
1994 2
1996 1
2000 3
2003 1
2004 1
2005 4
2006 4
2007 10
2008 10
2009 8
2010 12
2011 10
2012 18
2013 27
2014 23
2015 21
2016 14
2017 17
2018 19
2019 18
2020 20
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

339 results
Results by year
Filters applied: . Clear all
Page 1
Current status of theranostics in prostate cancer.
Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C. Virgolini I, et al. Among authors: haug a. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):471-495. doi: 10.1007/s00259-017-3882-2. Epub 2017 Dec 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29282518 Free PMC article. Review.
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks.
Rasul S, Hacker M, Kretschmer-Chott E, Leisser A, Grubmüller B, Kramer G, Shariat S, Wadsak W, Mitterhauser M, Hartenbach M, Haug AR. Rasul S, et al. Among authors: haug ar. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):713-720. doi: 10.1007/s00259-019-04584-1. Epub 2019 Nov 28. Eur J Nucl Med Mol Imaging. 2020. PMID: 31781834 Free PMC article.
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact.
Grubmüller B, Baltzer P, Hartenbach S, D'Andrea D, Helbich TH, Haug AR, Goldner GM, Wadsak W, Pfaff S, Mitterhauser M, Balber T, Berroteran-Infante N, Grahovac M, Babich J, Seitz C, Kramer G, Susani M, Mazal P, Kenner L, Shariat SF, Hacker M, Hartenbach M. Grubmüller B, et al. Among authors: haug ar. Clin Cancer Res. 2018 Dec 15;24(24):6300-6307. doi: 10.1158/1078-0432.CCR-18-0768. Epub 2018 Aug 23. Clin Cancer Res. 2018. PMID: 30139879 Free article.
Offene Fraktur.
Haug AT, Kanz KG, van Griensven M, Biberthaler P. Haug AT, et al. MMW Fortschr Med. 2017 May;159(9):56-58. doi: 10.1007/s15006-017-9652-z. MMW Fortschr Med. 2017. PMID: 28509014 Review. German. No abstract available.
[Hybrid imaging in lymphoma].
Mayerhöfer ME, Haug A. Mayerhöfer ME, et al. Among authors: haug a. Radiologe. 2020 May;60(5):376-385. doi: 10.1007/s00117-020-00676-4. Radiologe. 2020. PMID: 32296856 Review. German.
Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer.
Rasul S, Hartenbach M, Wollenweber T, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat S, Wadsak W, Mitterhauser M, Pichler V, Vraka C, Hacker M, Haug AR. Rasul S, et al. Among authors: haug ar. Eur J Nucl Med Mol Imaging. 2020 Oct 30. doi: 10.1007/s00259-020-05082-5. Online ahead of print. Eur J Nucl Med Mol Imaging. 2020. PMID: 33128131
Whole-Body [18F]FDG-PET/MRI vs. [18F]FDG-PET/CT in Malignant Melanoma.
Berzaczy D, Fueger B, Hoeller C, Haug AR, Staudenherz A, Berzaczy G, Weber M, Mayerhoefer ME. Berzaczy D, et al. Among authors: haug ar. Mol Imaging Biol. 2020 Jun;22(3):739-744. doi: 10.1007/s11307-019-01413-7. Mol Imaging Biol. 2020. PMID: 31363965
339 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page